Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations
暂无分享,去创建一个
H. Teppler | Valerie Teal | J. Mallolas | A. Rodgers | J. Molina | A. Pozniak | G. Hanna | A. Wong | E. Dejesus | Sushma Kumar | Margaret Johnson | C. Hwang | D. Goldstein | P. Sklar | C. Badshah | Deborah A Hepler